CAPTRUST Financial Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Sell
6,155
-1,033
-14% -$257K ﹤0.01% 1343
2025
Q4
$1.98M Buy
7,188
+323
+5% +$88.4K ﹤0.01% 1103
2025
Q3
$1.8M Buy
6,865
+1,985
+41% +$482K ﹤0.01% 1080
2025
Q2
$1.07M Buy
4,880
+320
+7% +$68.4K ﹤0.01% 1315
2025
Q1
$1.02M Buy
4,560
+194
+4% +$53.5K ﹤0.01% 1262
2024
Q4
$1.43M Sell
4,366
-1,568
-26% -$493K ﹤0.01% 1043
2024
Q3
$1.78M Buy
5,934
+1,265
+27% +$387K 0.01% 905
2024
Q2
$1.54M Buy
4,669
+611
+15% +$216K ﹤0.01% 937
2024
Q1
$1.61M Sell
4,058
-24,508
-86% -$9.07M 0.01% 896
2023
Q4
$10.1M Buy
28,566
+308
+1% +$109K 0.03% 370
2023
Q3
$10.6M Sell
28,258
-885
-3% -$342K 0.04% 327
2023
Q2
$11.1M Sell
29,143
-232
-0.8% -$82.9K 0.04% 310
2023
Q1
$10.2M Buy
29,375
+600
+2% +$175K 0.04% 294
2022
Q4
$6.77M Buy
28,775
+1,160
+4% +$275K 0.03% 374
2022
Q3
$6.8M Sell
27,615
-498
-2% -$152K 0.04% 327
2022
Q2
$8.5M Buy
28,113
+820
+3% +$267K 0.05% 276
2022
Q1
$11.2M Buy
27,293
+101
+0.4% +$39.5K 0.07% 223
2021
Q4
$12.8M Sell
27,192
-22,644
-45% -$9.75M 0.09% 203
2021
Q3
$21.2M Buy
49,836
+43
+0.1% +$18.1K 0.18% 138
2021
Q2
$17.9M Sell
49,793
-2,204
-4% -$728K 0.17% 139
2021
Q1
$14.7M Buy
51,997
+641
+1% +$183K 0.16% 139
2020
Q4
$14.6M Sell
51,356
-100
-0.2% -$28.1K 0.19% 125
2020
Q3
$14.2M Sell
51,456
-307
-0.6% -$81.2K 0.24% 110
2020
Q2
$11.6M Sell
51,763
-876
-2% -$172K 0.19% 128
2020
Q1
$7.88M Buy
52,639
+14
+0% +$2.15K 0.17% 141
2019
Q4
$7.99M Buy
52,625
+51,432
+4,311% +$7.49M 0.13% 173
2019
Q3
$169K Sell
1,193
-151
-11% -$20.8K 0.01% 613
2019
Q2
$168K Buy
1,344
+52
+4% +$6.14K 0.01% 603
2019
Q1
$142K Sell
1,292
-47
-4% -$4.89K 0.01% 589
2018
Q4
$131K Buy
1,339
+230
+21% +$25K 0.01% 519
2018
Q3
$137K Sell
1,109
-536
-33% -$60.1K 0.01% 509
2018
Q2
$163K Buy
1,645
+50
+3% +$4.6K 0.01% 406
2018
Q1
$136K Buy
1,595
+328
+26% +$30.7K 0.01% 388
2017
Q4
$125K Buy
+1,267
New +$124K 0.01% 401

Other funds holding WST